Controversies in Modern Eye Care 2023: That's a wrap!

Video

The co-chairs of the 2023 Controversies in Modern Eye Care symposium reflect on the day.

Robert Maloney, MD; Neda Shamie, MD; and Arjan Hura, MD, all of the Maloney-Shamie Vision Institute, share reflections on the 17th annual Controversies in Modern Eye Care symposium at the Skirball Cultural Center in Los Angeles, California.

This transcript has been edited for clarity.

Robert Maloney, MD:

Well, it was quite a day, we had 8 hours of CE credits. We covered glaucoma, thyroid disease, retinal disease, including geographic atrophy and wet AMD. We covered advances and cataract surgery, advances in refractive surgery. We didn't leave much out.

Neda Shamie, MD:

We didn't. It was quite a day and a lot of exciting talks—a lot of relevant talks—talking about present offerings to our patients, advances in technology, future offerings, and I'm going to leave this meeting having learned a lot. And probably the most favorite part of this meeting is the opportunity to see friends and colleagues and really be able to really connect on a personal level, too.

Arjan Hura, MD:

Yeah, just such an amazing event being back in person for the first time in 3 years. We had almost 300-400 people in attendance and another 500 or so live virtually. So really just a great turnout. Wonderful seeing everyone again in person, just so great to share that energy. Everyone's so enthusiastic about eye care and giving the best for their patients. We couldn't be more happy without this one. And we can't wait to see you guys next year, Cinco de Mayo potentially. Join us

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
© 2025 MJH Life Sciences

All rights reserved.